Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drospirenone/Ethinylestradiol for Dysmenorrhea
NCT00461305Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in dysmenorrhea, sponsored by Bayer. Started Feb 2007; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT00461305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461305.